Publications
Marden E & Godfrey R Nelson (2012) Intellectual Property and Sharing Regimes in Agricultural Genomics: Finding the Right Balance for Innovation. 17:2 Drake Journal of Agricultural Law [manuscript accepted].
Marden E, Voell MR, Godfrey RN & Rieseberg L (2011) The Potential for Canadian Developed Products of Agricultural Genomics: A Dual Use Food and Fuel Sunflower. Canadian Journal or Environmental Law & Practice [manuscript under review].
Godfrey, R Nelson (2011) The environmental regulation of genetically modified microorganisms in Canada: Case studies of a piecemeal approach sorely in need of reform. Canadian Journal of Environmental Law & Practice [manuscript under review].
Goulding R, Voell MR, Marden E & Levy E (2011) Expansion of the Canadian Research Exemption for Biotechnology Research Tools. 30 Biotechnology Law Report 59.
Voell MR., Farris, L., Levy E. & Marden E. (2010) A Response to Rome: Pre- and Post-Publication Sharing in the C. elegans Research Community. BMC Genomics, 11:708.
Goulding R., Marden, E., Manion R. & Levy, E. (2010) Alternative Intellectual Property for Genomics and the Activity of Technology Transfer Offices: Emerging Directions in Research. Boston University Journal of Science and Technology Law 16(2):194-230.
Marden E., (2010) Open Source Drug Development: A Path to More Accessible Drugs and Diagnostics? Minnesota Journal of Law, Science and Technology 11(1):217-266.
Levy, E., Marden, E., Warren, B., Hartell, D. and Filaté I. (2010) Patent Pools and Genomics: Navigating a Course to Open Science? Boston University Journal of Science and Technology Law 16(1):75-101.
Marden, E., Longstaff, H., and Levy, E. (2008) Transgenic salmon: Regulatory oversight of an anticipated technology. In: Emerging technologies: hindsight and foresight, edited by E. Einsiedel. UBC Press, Vancouver.
Marden, E., Power, C., Hartell, D., Levy, E., and Warren, B. (2008) Genomics and Intellectual Property: Considering Alternative to Traditional Patenting Health Law Review 17(1): 12-20.
Power, C., Levy, E., Marden, E., and Warren, B. (2008) Alternative IP mechanisms in genomic research Studies in Ethics, Law, and Technology 2(2):Article 5.
Blouin, C., Bhushan, A., Murphy, S., and Warren B. (2007) Trade Liberalisation: Globalisation Knowledge Network Synthesis Paper 4 University of Ottawa’s Institute on Population Health.
Danielson, P., Ahmad, R., Bornik, Z., Dowlatabadi, H., and Levy, E. (2007) Deep, Cheap, and Improvable: Dynamic Democratic Norms & the Ethics of Biotechnology Journal of Philosophical Research: Supplementary Volume Special Issue on Ethics and the Life Sciences.
Marden, E. (2007) Book Review: Regulation of the Pharmaceutical Industry Science, Technology & Human Values 32(2):250-257.
Power, C. (2007) MORGEN and data release policies: An Overview Health Law Review 15(3):9-11.
Marden, E., Longstaff, H., and Levy, E. (2006) The policy context and public consultation: A consideration of transgenic salmon Journal of Integrated Assessment 6(2): 73-97.
___________________
Recent Presentations
Godfrey R Nelson, (2011) “Socially Beneficial Agricultural Genomics: Regulatory and Intellectual Property Hurdles in Canada and Abroad” Student Biotechnology Network: Research Exchange, Vancouver, BC, March 26, 2011.
Goulding R, (2010) “Alternative Licensing Solutions for Global Access” Open Science Summit 2010: Updating the Social Contract for Science, Berkeley, CA, July 29-31, 2010.
Marden E, Levy E, (2010) “Objectivity and Regulation: Systemic Impacts of Law and Regulation” at Objectivity in Science Conference, UBC, June 19, 2010.
Marden E, “Open Source Drug Development” Ten Years After – Mapping the societal landscape of genomics. The Royal Tropical Institute, Amsterdam International Scientific Conference. May 27-28, 2010. Amsterdam, Netherlands.
Voell MR, “Conceptual elements of open source architectures in biotechnology” Reflexive Governance in the Public Interest – Democratic Governance and Collective Action, Palais des Académies, Brussels, Belgium, May 27, 2010.
Goulding R, (2010) “Intellectual Property Policy and Access to Essential Medicines” Global Health and Human Security Conference 2010, The Lack of Access to Essential Medicines, The Liu Institute of Global Issues, UBC, March 26-28 2010.
Goulding R, Marden E and Levy E, (2009) “Intellectual Property and the Translation of Genomics Discoveries: Issues and Alternatives.” MORGEN group weekly meeting. BC Cancer Research Centre Dec 2, 2009.
Goulding R, Marden E and Levy E, (2009) “Open Source Licensing for Genomics: Overcoming Hurdles in Implementation.” Health Innovation for Patients and Populations: Science, Systems & Structures. The 21st Health Policy Conference of the UBC Centre for Health Services and Policy Research, Sheraton Wall Centre, Vancouver, 24-25 February 2009.
Goulding R, Filate I, Marden E and Levy E, (2008) “The Cre-lox controversy: What can we learn?” Genome Canada International Conference. Four Seasons Hotel, Vancouver, October 22-24, 2008.
Marden E, Levy E, Goulding R, Filate I and Farris L, (2008) “Open Source and Genomics: A Path Forward for Upstream Intellectual Property.” Genome Canada International Conference. Four Seasons Hotel, Vancouver, October 22-24, 2008.
Goulding RE, Farris F, Warren B, Marden E and Levy E, (2008). “Genomics Gate-keepers: Technology Transfer Offices, IP Policy Development and the Updtake of Alternative Licensing Practices.” Genome Canada International GE3LS Symposium. Calgary, Alberta, April 29-30.
Marden E, Farris F, Warren B, Hartell D, Goulding RE and Levy E, (2008). “Open Source as an Alternative for Biobanks.” Translating ‘ELSI’: Ethical, Legal and Social Implications of Genomics. Case Western Reserve, Cleveland, May 1.
